Scout | Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)

This opportunity is no longer accepting applications.

grant

Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)

This grant opportunity is for research on creating and testing new radioligands used in brain imaging through PET or SPECT scans. It aims to gather data from these studies to support the use of promising PET ligands in clinical research. Researchers are encouraged to incorporate findings from past pre-clinical studies to evaluate the feasibility of these developments.

Source

Agency: National Institutes of Health

Sub-agency: National Institute of Mental Health

Program: SBIR

Dates

Opportunity Released: April 7, 2023

Open for Submission: April 7, 2023

Submission Deadline: May 7, 2026

Application Window Closes: May 7, 2026

Keywords

radioligands

positron emission tomography

PET imaging

single photon emission computed tomography

SPECT imaging

human brain

clinical research

pre-clinical studies

grant applications

feasibility evaluation

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers